These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38935906)

  • 1. Candida albicans-A systematic review to inform the World Health Organization Fungal Priority Pathogens List.
    Parambath S; Dao A; Kim HY; Zawahir S; Izquierdo AA; Tacconelli E; Govender N; Oladele R; Colombo A; Sorrell T; Ramon-Pardo P; Fusire T; Gigante V; Sati H; Morrissey CO; Alffenaar JW; Beardsley J
    Med Mycol; 2024 Jun; 62(6):. PubMed ID: 38935906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List.
    Beardsley J; Kim HY; Dao A; Kidd S; Alastruey-Izquierdo A; Sorrell TC; Tacconelli E; Chakrabarti A; Harrison TS; Bongomin F; Gigante V; Galas M; Siswanto S; Dagne DA; Roitberg F; Sati H; Morrissey CO; Alffenaar JW
    Med Mycol; 2024 Jun; 62(6):. PubMed ID: 38935913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida tropicalis-A systematic review to inform the World Health Organization of a fungal priority pathogens list.
    Keighley C; Kim HY; Kidd S; Chen SC; Alastruey A; Dao A; Bongomin F; Chiller T; Wahyuningsih R; Forastiero A; Al-Nuseirat A; Beyer P; Gigante V; Beardsley J; Sati H; Morrissey CO; Alffenaar JW
    Med Mycol; 2024 Jun; 62(6):. PubMed ID: 38935905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens list.
    Asogan M; Kim HY; Kidd S; Alastruey-Izquierdo A; Govender NP; Dao A; Shin JH; Heim J; Ford NP; Gigante V; Sati H; Morrissey CO; Alffenaar JW; Beardsley J
    Med Mycol; 2024 Jun; 62(6):. PubMed ID: 38935912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens.
    Nguyen TA; Kim HY; Stocker S; Kidd S; Alastruey-Izquierdo A; Dao A; Harrison T; Wahyuningsih R; Rickerts V; Perfect J; Denning DW; Nucci M; Cassini A; Beardsley J; Gigante V; Sati H; Morrissey CO; Alffenaar JW
    Med Mycol; 2024 Jun; 62(6):. PubMed ID: 38935911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida auris-a systematic review to inform the world health organization fungal priority pathogens list.
    Kim HY; Nguyen TA; Kidd S; Chambers J; Alastruey-Izquierdo A; Shin JH; Dao A; Forastiero A; Wahyuningsih R; Chakrabarti A; Beyer P; Gigante V; Beardsley J; Sati H; Morrissey CO; Alffenaar JW
    Med Mycol; 2024 Jun; 62(6):. PubMed ID: 38935900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
    Wang B; Wang Y; Zhang L; Lu F; Zhang M; Xu Y
    Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the epidemiological landscape of invasive candidiasis.
    Lamoth F; Lockhart SR; Berkow EL; Calandra T
    J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i4-i13. PubMed ID: 29304207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.
    Roilides E; Farmaki E; Evdoridou J; Dotis J; Hatziioannidis E; Tsivitanidou M; Bibashi E; Filioti I; Sofianou D; Gil-Lamaignere C; Mueller FM; Kremenopoulos G
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):745-50. PubMed ID: 15605181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility.
    Nieto MC; Tellería O; Cisterna R
    Diagn Microbiol Infect Dis; 2015 Jan; 81(1):34-40. PubMed ID: 25439581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.
    Quindós G; Marcos-Arias C; San-Millán R; Mateo E; Eraso E
    Int Microbiol; 2018 Sep; 21(3):107-119. PubMed ID: 30810955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.
    Farooqi JQ; Jabeen K; Saeed N; Iqbal N; Malik B; Lockhart SR; Zafar A; Brandt ME; Hasan R
    J Med Microbiol; 2013 Feb; 62(Pt 2):259-268. PubMed ID: 23105021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.
    Xiao M; Sun ZY; Kang M; Guo DW; Liao K; Chen SC; Kong F; Fan X; Cheng JW; Hou X; Zhou ML; Li Y; Yu SY; Huang JJ; Wang H; Xu YC;
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study.
    Cook A; Ferreras-Antolin L; Adhisivam B; Ballot D; Berkley JA; Bernaschi P; Carvalheiro CG; Chaikittisuk N; Chen Y; Chibabhai V; Chitkara S; Chiurchiu S; Chorafa E; Dien TM; Dramowski A; de Matos SF; Feng J; Jarovsky D; Kaur R; Khamjakkaew W; Laoyookhong P; Machanja E; Mussi-Pinhata MM; Namiiro F; Natraj G; Naziat H; Ngoc HTB; Ondongo-Ezhet C; Preedisripipat K; Rahman H; Riddell A; Roilides E; Russell N; Sastry AS; Tasimwa HB; Tongzhen J; Wadula J; Wang Y; Whitelaw A; Wu D; Yadav V; Yang G; Stohr W; Bielicki JA; Ellis S; Warris A; Heath PT; Sharland M
    Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36881725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Wang H; Xu YC; Hsueh PR
    Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between antifungal consumption and the distribution of Candida species in different hospital departments of a Lebanese medical Centre.
    Awad L; Tamim H; Abdallah D; Salameh M; Mugharbil A; Jisr T; Zahran K; Droubi N; Ibrahim A; Moghnieh R
    BMC Infect Dis; 2018 Nov; 18(1):589. PubMed ID: 30453891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
    Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
    Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.